Pancreatic Cancer Research

ResearcherStanford MedicineActive in the last 2 years

Amanda Kirane

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3489-1182; OpenAlex author ID A5022984263. Sources: OpenAlex.

Their work

Papers
6 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
27
Papers, trials and grants by year

2011: 1 paper · 2012: 1 paper · 2013: none · 2014: none · 2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper · 2026: 1 paper

Papers 6

  1. Biochemical, Radiographic, or Pathologic Response to Neoadjuvant Chemotherapy in Resected Pancreatic Cancer: Which Is Best? Co-author DOI 10.1097/sla.0000000000006609↗
  2. Disruption of fibroblast MYD88 signaling promotes antitumor immunity in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.celrep.2025.116347↗
  3. Cyclooxygenase-2 Inhibition Potentiates the Efficacy of Vascular Endothelial Growth Factor Blockade and Promotes an Immune Stimulatory Microenvironment in Prec… First author DOI 10.1158/1541-7786.mcr-18-0427↗
  4. Warfarin Blocks Gas6-Mediated Axl Activation Required for Pancreatic Cancer Epithelial Plasticity and Metastasis. Co-author DOI 10.1158/0008-5472.can-14-2887-t↗
  5. Apricoxib, a novel inhibitor of COX-2, markedly improves standard therapy response in molecularly defined models of pancreatic cancer. Co-author DOI 10.1158/1078-0432.ccr-12-0453↗
  6. Smac mimetic-derived augmentation of chemotherapeutic response in experimental pancreatic cancer. First author DOI 10.1186/1471-2407-11-15↗

Closest collaborators

The 25 strongest of 27 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. George A. Poultsides · 2 shared papers, 2025–2026 · strength 0.42
  2. Byrne Lee · 2 shared papers, 2025–2026 · strength 0.42
  3. Daniel Delitto · 2 shared papers, 2025–2026 · strength 0.42
  4. Brendan Christopher Visser · 2 shared papers, 2025–2026 · strength 0.42
  5. Jeffrey Allen Norton · 2 shared papers, 2025–2026 · strength 0.42
  6. M. Usman Ahmad · 1 shared paper, 2026 · strength 0.24
  7. Gregory M. Heestand · 1 shared paper, 2026 · strength 0.24
  8. Erqi Liu Pollom · 1 shared paper, 2026 · strength 0.24
  9. Daniel Tandel Chang · 1 shared paper, 2026 · strength 0.24
  10. George Albert Fisher · 1 shared paper, 2026 · strength 0.24
  11. Rolf A. Brekken · 4 shared papers, 2011–2019 · strength 0.21
  12. Maria Moozhiyil Korah · 1 shared paper, 2025 · strength 0.17
  13. James Paul Agolia · 1 shared paper, 2025 · strength 0.17
  14. Deshka S. Foster · 1 shared paper, 2025 · strength 0.17
  15. Jason L. Guo · 1 shared paper, 2025 · strength 0.17
  16. Michael Thornton Longaker · 1 shared paper, 2025 · strength 0.17
  17. Chuner Guo · 1 shared paper, 2025 · strength 0.17
  18. Noah B. Sorrelle · 2 shared papers, 2015–2019 · strength 0.15
  19. Francis J. Burrows · 2 shared papers, 2012–2019 · strength 0.14
  20. Huocong Huang · 1 shared paper, 2019 · strength 0.11
  21. Yuqing Zhang · 1 shared paper, 2019 · strength 0.11
  22. Roderich Egbert Schwarz · 2 shared papers, 2011–2012 · strength 0.06
  23. Miao Wang · 1 shared paper, 2015 · strength 0.04
  24. Kathleen F. Ludwig · 1 shared paper, 2015 · strength 0.04
  25. Margaret A. Schwarz · 1 shared paper, 2011 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.